Synthesis, characterization, and degradation of silicon(IV) phthalocyanines conjugated axially with poly(sebacic anhydride)

Journal of Polymer Science, Part A: Polymer Chemistry

Volumn 43, Issue 4, 2005, Pages 837-843

  Lee, Priscilla P S ^a   Ngai, T O ^a   Yang, Cheng ^a   Wu, Chi ^a   Ng, Dennis K P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Degradation; Light scattering; Nanoparticles; Phthalocyanines; Polyanhydrides

Indexed keywords

CONDENSATION; DEGRADATION; FLUORESCENCE; GEL PERMEATION CHROMATOGRAPHY; HYDRODYNAMICS; LIGHT SCATTERING; MOLECULAR WEIGHT; NANOSTRUCTURED MATERIALS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGANIC POLYMERS; SURFACE ACTIVE AGENTS; SYNTHESIS (CHEMICAL);

FLUORESCENCE SPECTROSCOPY; NANOPARTICLES; PHTHALOCYANINES; POLYANHYDRIDES;

SILICON COMPOUNDS;

EID: 13444291517     PISSN: 0887624X     EISSN: None     Source Type: Journal    
DOI: 10.1002/pola.20561     Document Type: Article

References (35)

1. (a) Ali, H.; van Lier, J. E. Chem Rev 1999, 99, 2379.
2. (b) Tedesco, A. C.; Rotta, J. C. G.; Lunardi, C. N. Curr Org Chem 2003, 7, 187.
3. Konan, Y. N.; Gurny, R.; Allémann, E. J Photochem Photobiol B: Biol 2002, 66, 89.
4. (a) Yang, L.; Alewandridis, P. Curr Opin Colloid Interface Sci 2000, 5, 132.
5. (b) Kong, G.; Braun, R. D.; Dewhirst, M. W. Cancer Res 2000, 60, 4440.
6. (c) Barratt, G. Cell Mol Life Sci 2003, 60, 21.
7. (a) Soppimath, K. S.; Aminabhavi, T. M.; Kulkarni, A. R.; Rudzinski, W. E. J Controlled Release 2001, 70, 1.
8. (b) Katti, D. S.; Lakshmi, S.; Langer, R.; Laurencin, C. T. Adv Drug Delivery Rev 2002, 54, 933.
9. (c) Tarvainen, T.; Karjalainen, T.; Malin, M.; Peräkorpi, K.; Tuominen, J.; Seppälä, J.; Järvinen, K. Eur J Pharm Sci 2002, 16, 323.
10. (d) Mu, L.; Feng, S. S. J Controlled Release 2003, 86, 33.
11. See for example: (a) Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schafer, U.; Takeuchi, H.; Maincent, P.; Kawashima, Y.; Lehr, C. M. J. Pharmacol Exp Ther 2001, 299, 775. (b) Kreuter, J. Adv Drug Delivery Rev 2001, 47, 65. (c) Lockman, P. R.; Mumper, R. J.; Khan, M. A.; Allen, D. D. Drug Dev Ind Pharm 2002, 28, 1. (d) Chawla, J. S.; Amiji, M. M. Int J Pharm 2002, 249, 127. (e) Kim, I. S.; Kim, S. H. Int J Pharm 2003, 257, 195.
12. See for example: (a) Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schafer, U.; Takeuchi, H.; Maincent, P.; Kawashima, Y.; Lehr, C. M. J. Pharmacol Exp Ther 2001, 299, 775. (b) Kreuter, J. Adv Drug Delivery Rev 2001, 47, 65. (c) Lockman, P. R.; Mumper, R. J.; Khan, M. A.; Allen, D. D. Drug Dev Ind Pharm 2002, 28, 1. (d) Chawla, J. S.; Amiji, M. M. Int J Pharm 2002, 249, 127. (e) Kim, I. S.; Kim, S. H. Int J Pharm 2003, 257, 195.
13. See for example: (a) Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schafer, U.; Takeuchi, H.; Maincent, P.; Kawashima, Y.; Lehr, C. M. J. Pharmacol Exp Ther 2001, 299, 775. (b) Kreuter, J. Adv Drug Delivery Rev 2001, 47, 65. (c) Lockman, P. R.; Mumper, R. J.; Khan, M. A.; Allen, D. D. Drug Dev Ind Pharm 2002, 28, 1. (d) Chawla, J. S.; Amiji, M. M. Int J Pharm 2002, 249, 127. (e) Kim, I. S.; Kim, S. H. Int J Pharm 2003, 257, 195.
14. See for example: (a) Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schafer, U.; Takeuchi, H.; Maincent, P.; Kawashima, Y.; Lehr, C. M. J. Pharmacol Exp Ther 2001, 299, 775. (b) Kreuter, J. Adv Drug Delivery Rev 2001, 47, 65. (c) Lockman, P. R.; Mumper, R. J.; Khan, M. A.; Allen, D. D. Drug Dev Ind Pharm 2002, 28, 1. (d) Chawla, J. S.; Amiji, M. M. Int J Pharm 2002, 249, 127. (e) Kim, I. S.; Kim, S. H. Int J Pharm 2003, 257, 195.
15. See for example: (a) Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schafer, U.; Takeuchi, H.; Maincent, P.; Kawashima, Y.; Lehr, C. M. J. Pharmacol Exp Ther 2001, 299, 775. (b) Kreuter, J. Adv Drug Delivery Rev 2001, 47, 65. (c) Lockman, P. R.; Mumper, R. J.; Khan, M. A.; Allen, D. D. Drug Dev Ind Pharm 2002, 28, 1. (d) Chawla, J. S.; Amiji, M. M. Int J Pharm 2002, 249, 127. (e) Kim, I. S.; Kim, S. H. Int J Pharm 2003, 257, 195.
16. (a) Labib, A.; Lenaerts, V.; Chouinard, F.; Leroux, J. C.; Ouellet, R.; van Lier, J. E. Pharm Res 1991, 8, 1027.
17. (b) Allémann, E.; Rousseau, J.; Brasseur, N.; Kudrevich, S. V.; Lewis, K.; van Lier, J. E. Int J Cancer 1996, 66, 821.
18. (c) Leroux, J. C.; Allémann, E.; DeJaeghere, F.; Doelker, E.; Gurny, R. J Controlled Release 1996, 39, 339.
19. (d) Taillefer, J.; Brasseur, N.; van Lier, J. E.; Lenaerts, V.; Le Garrec, D.; Leroux, J.-C. J Pharm Pharmacol 2001, 53, 155.
20. (e) Le Garrec, D.; Taillefer, J.; van Lier, J. E.; Lenaerts, V.; Leroux, J.-C. J. Drug Target 2002, 10, 429.
21. (f) Lee, P. P. S.; Ngai, T.; Huang, J.-D.; Wu, C.; Fong, W.-P.; Ng, D. K. P. Macromolecules 2003, 36, 7527.
22. Fu, J.; Li, X.-Y.; Ng, D. K. P.; Wu, C. Langmuir 2002, 18, 3843.
23. Davison, J. B.; Wynne, K. J. Macromolecules 1978, 11, 186.
24. Ferraudi, G. In Phthalocyanines - Properties and Applications; Leznoff, C. C., Lever, A. B. P., Eds.; VCH: New York, 1989; Vol. 1, p 301.
25. Spiller, W.; Kliesch, H.; Wöhrle, D.; Hackbarth, S.; Röder, B.; Schnurpfeil, G. J. Porphyrins Phthalocyanines 1998, 2, 145.
26. (a) Berne, B.; Pecora, R. Dynamic Light Scattering; Plenum Press: New York, 1976.
27. (b) Chu, B. Laser Light Scattering, 2nd ed.; Academic Press: New York, 1991.
28. (c) Wu, C.; Zhou, S. Q. Macromolecules 1995, 28, 8381.
29. (d) Wu, C.; Zhou, S. Q. Macromolecules 1996, 29, 1574.
30. Leong, K. W.; Simonte, V.; Langer, R. Macromolecules 1987, 20, 705.
31. 2).
32. Huang, J.-D.; Wang, S.; Lo, P.-C.; Fong, W.-P.; Ko, W.-H.; Ng, D. K. P. New J Chem 2004, 28, 348.
33. Tu, Y.; Wan, X.; Zhang, D.; Zhou, Q.; Wu, C. J Am Chem Soc 2000, 122, 10201.
34. Wu, C.; Fu, J.; Zhao, Y. Macromolecules 2000, 33, 9040.
35. Fu, J.; Wu, C. J Polym Sci Part B: Polym Phys 2001, 39, 703.